6 Analysts Assess Doximity: What You Need To Know
Portfolio Pulse from Benzinga Insights
Doximity (NYSE:DOCS) has been analyzed by 6 analysts, showing a shift towards a more neutral stance in the last three months with 5 indifferent ratings recently. The average 12-month price target for DOCS is now $29.17, up from $26.00, indicating a 12.19% increase. The company's financial health appears strong, with significant revenue growth, high net margin, and efficient asset and equity management. Analysts' actions and price target adjustments reflect their response to Doximity's performance and market conditions.
April 02, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Doximity has received a neutral outlook from analysts, with a revised average price target of $29.17, indicating potential growth. The company's strong financial performance, including revenue growth and profitability, supports a positive short-term outlook.
The increase in the average price target to $29.17 from $26.00 reflects analysts' positive reassessment of Doximity's value, likely influenced by its strong financial performance and market position. The company's solid revenue growth, high net margin, and efficient management suggest a robust financial health, which could drive investor interest and support a positive short-term price movement.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100